Global Market Direct’s pharmaceuticals report, “Oncothyreon Inc. - Product Pipeline Review - 2013” provides data on the Oncothyreon Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Oncothyreon Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from Oncothyreon Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.
- Oncothyreon Inc. - Brief Oncothyreon Inc. overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of Oncothyreon Inc. human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of Oncothyreon Inc. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the Oncothyreon Inc.’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products.
Reasons to buy
- Evaluate Oncothyreon Inc.’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of Oncothyreon Inc. in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the Oncothyreon Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with Oncothyreon Inc.. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of Oncothyreon Inc. and identify potential opportunities in those areas.
Table Of Contents
Oncothyreon Inc. - Product Pipeline Review - 2013 Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 3 Oncothyreon Inc. Snapshot 4 Oncothyreon Inc. Overview 4 Key Information 4 Key Facts 4 Oncothyreon Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 Oncothyreon Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Oncothyreon Inc. - Pipeline Products Glance 9 Oncothyreon Inc. Clinical Stage Pipeline Products 9 Phase II Products/Combination Treatment Modalities 9 Phase I Products/Combination Treatment Modalities 10 Oncothyreon Inc. - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 Oncothyreon Inc. - Drug Profiles 12 ONT-10 12 Product Description 12 Mechanism of Action 12 RandD Progress 12 ONT-701 13 Product Description 13 Mechanism of Action 13 RandD Progress 13 PX-866 14 Product Description 14 Mechanism of Action 14 RandD Progress 14 Oncothyreon Inc. - Pipeline Analysis 15 Oncothyreon Inc. - Pipeline Products by Therapeutic Class 15 Oncothyreon Inc. - Pipeline Products By Target 16 Oncothyreon Inc. - Pipeline Products by Route of Administration 17 Oncothyreon Inc. - Pipeline Products By Mechanism of Action 18 Oncothyreon Inc. - Recent Pipeline Updates 19 Oncothyreon Inc. - Dormant Projects 22 Oncothyreon Inc. - Discontinued Pipeline Products 23 Discontinued Pipeline Product Profiles 23 PX-478 23 Theratope 23 Oncothyreon Inc. - Locations And Subsidiaries 24 Head Office 24 Other Locations and Subsidiaries 24 Appendix 25 Methodology 25 Coverage 25 Secondary Research 25 Primary Research 25 Expert Panel Validation 25 Contact Us 26 Disclaimer 26
List of Tables
Oncothyreon Inc., Key Information 4 Oncothyreon Inc., Key Facts 4 Oncothyreon Inc. - Pipeline by Indication, 2013 6 Oncothyreon Inc. - Pipeline by Stage of Development, 2013 7 Oncothyreon Inc. - Monotherapy Products in Pipeline, 2013 8 Oncothyreon Inc. - Phase II, 2013 9 Oncothyreon Inc. - Phase I, 2013 10 Oncothyreon Inc. - Preclinical, 2013 11 Oncothyreon Inc. - Pipeline By Therapeutic Class, 2013 15 Oncothyreon Inc. - Pipeline By Target, 2013 16 Oncothyreon Inc. - Pipeline By Route of Administration, 2013 17 Oncothyreon Inc. - Pipeline Products By Mechanism of Action, 2013 18 Oncothyreon Inc. - Recent Pipeline Updates, 2013 19 Oncothyreon Inc. - Dormant Developmental Projects,2013 22 Oncothyreon Inc. - Discontinued Pipeline Products, 2013 23 Oncothyreon Inc., Subsidiaries 24
List of Figures
Oncothyreon Inc. - Pipeline by Indication, 2013 6 Oncothyreon Inc. - Pipeline by Stage of Development, 2013 7 Oncothyreon Inc. - Monotherapy Products in Pipeline, 2013 8 Oncothyreon Inc. - Pipeline By Therapeutic Class, 2013 15 Oncothyreon Inc. - Pipeline By Route of Administration, 2013 17 Oncothyreon Inc. - Pipeline Products By Mechanism of Action, 2013 18